Literature DB >> 11097723

Carcinoma of the Pancreas.

.   

Abstract

Carcinoma of the pancreas remains a formidable challenge for clinicians. Pancreatic cancer is the tenth most common type of new cancer, and according to estimates of the American Cancer Society, 29,000 new cases occurred in 1998. The relative frequency of the disease is compounded by its lethality. Pancreatic cancer accounts for 5% and 6% of cancer deaths among men and women respectively, making it the fourth leading site of cancer deaths. In 1998, an estimated 28,000 deaths from pancreatic cancer were expected. The five-year relative survival rate for pancreatic cancer between 1986 and 1993, as reported by the NCI Surveillance, Epidemiology, and End Results Program, was only 4%. Although this was a statistically significant increase from the 3% five-year survival rate for pancreatic cancer between 1974 and 1976 it remained the lowest survival rate among all reported sites. By comparison, survival for gastric and esophageal cancers during the more recent reporting period were 19% and 12% respectively.

Entities:  

Year:  1999        PMID: 11097723     DOI: 10.1007/s11938-999-0062-x

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  16 in total

1.  Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

Authors:  C J Yeo; R A Abrams; L B Grochow; T A Sohn; S E Ord; R H Hruban; M L Zahurak; W C Dooley; J Coleman; P K Sauter; H A Pitt; K D Lillemoe; J L Cameron
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

2.  Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality.

Authors:  M Trede; G Schwall; H D Saeger
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

3.  Differentiation of benign from malignant pancreatic masses by endoscopic ultrasound.

Authors:  P L Baron; L E Aabakken; D J Cole; M B LeVeen; L F Baron; D M Daniel; J T Cunningham; R H Hawes; D B Adams; B J Hoffman
Journal:  Ann Surg Oncol       Date:  1997-12       Impact factor: 5.344

4.  Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study.

Authors:  J P Hoffman; S Lipsitz; T Pisansky; J L Weese; L Solin; A B Benson
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

5.  Pancreas cancer resection outcome in American University centers in 1989-1990.

Authors:  S B Edge; R E Schmieg; L K Rosenlof; M C Wilhelm
Journal:  Cancer       Date:  1993-06-01       Impact factor: 6.860

6.  Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head.

Authors:  C A Staley; J E Lee; K R Cleary; J L Abbruzzese; C J Fenoglio; T A Rich; D B Evans
Journal:  Am J Surg       Date:  1996-01       Impact factor: 2.565

7.  The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy.

Authors:  K C Conlon; E Dougherty; D S Klimstra; D G Coit; A D Turnbull; M F Brennan
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

8.  Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.

Authors:  C J Yeo; J L Cameron; K D Lillemoe; J V Sitzmann; R H Hruban; S N Goodman; W C Dooley; J Coleman; H A Pitt
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

9.  Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms.

Authors:  G M Fuhrman; C Charnsangavej; J L Abbruzzese; K R Cleary; R G Martin; C J Fenoglio; D B Evans
Journal:  Am J Surg       Date:  1994-01       Impact factor: 2.565

10.  A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma.

Authors:  J P Hoffman; J L Weese; L J Solin; P Agarwal; P Engstrom; R Scher; A R Paul; S Litwin; P Watts; B L Eisenberg
Journal:  Am Surg       Date:  1993-11       Impact factor: 0.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.